Skip to main content
Autobound logo
West Pharmaceutical Services10-K: Market share loss

Facing market share risk from customer shift to oral GLP-1s away from injectables

Read at SEC EDGAR

What happened

The company's business, which is highly dependent on injectable drug delivery systems for products like GLP-1s, is directly threatened by the potential industry shift to oral medications. This creates urgent pressure to innovate or diversify product offerings to avoid losing market share.

Source

Other signals in this filing (10)

Extracted by Autobound

From the Signal API record
Signal
10-K: Market share loss

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2025
Fiscal year end
12/31
Filed
Feb 17, 2026

More from West Pharmaceutical Services

Company page →

More 10-K signals at other companies

The full record

From the Signal API record

Details

CIK
105770
Accession number
0000105770-26-000010
Timeframe
Current year
Filing year
2026
Why it matters
Urgency to improve

Extraction

Confidence
High
Relevance
90%
Sentiment
Negative
Detected
Feb 24, 2026
signal_type
sec-10k
signal_subtype
marketShareLoss

Use this data

Get every 10-K signal for West Pharmaceutical Services and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at West Pharmaceutical Services this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/57b1f2e1-3502-447a-976c-9ce688348e20 returns this record as JSON. POST /v1/companies/enrich returns every signal for westpharma.com.

{
  "signal_id": "57b1f2e1-3502-447a-976c-9ce688348e20",
  "signal_type": "sec-10k",
  "signal_subtype": "marketShareLoss",
  "detected_at": "2026-02-24T09:29:10.462+00:00",
  "company": {
    "name": "West Pharmaceutical Services",
    "domain": "westpharma.com"
  },
  "data": {
    "detail": "The company's business, which is highly dependent on injectable drug delivery systems for products like GLP-1s, is directly threatened by the potential industry shift to oral medications. This creates urgent pressure to innovate or diversify product offerings to avoid losing market share.",
    "metrics": {
      "timeframe": "current_year"
    },
    "summary": "Facing market share risk from customer shift to oral GLP-1s away from injectables",
    "excerpts": "Our sales and profitability are largely dependent on the sale of drug products delivered by injection and the packaging of drug products.",
    "relevance": 0.9,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/105770/000010577026000010/wst-20251231.htm",
    "filing_date": "2026-02-17",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Urgency to improve",
    "signal_category": "market"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.